KV PHARMACEUTICAL CO /DE/
4, 1997-06-09
PHARMACEUTICAL PREPARATIONS
Previous: KIT MANUFACTURING CO, 10-Q, 1997-06-09
Next: LOEHMANNS INC, SC 13G/A, 1997-06-09



                                                  ------------------------------
                                                           OMB APPROVAL
                                                  ------------------------------
                                                  OMB Number           3235-0287
                                                  Expires:   September 30, 1998
                                                  Estimated average burden
                                                  hours per response ....... 1.0
                                                  ------------------------------
                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                     FORM 4

                  STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed  pursuant to Section  16(a) of the  Securities  Exchange  Act of 1934,
       Section 17(a) of the Public Utility Holding Company Act of 1935 or
               Section 30(f) of the Investment Company Act of 1940

[  ] Check this box if no longer subject of Section 16. Form 4 or Form 5
     obligations may continue. See Instruction 1(b).

================================================================================
1. Name and Address of Reporting Person

  Hermelin               Marc                       S.
- --------------------------------------------------------------------------------
   (Last)               (First)                 (Middle)

  2503 South Hanley Road
- --------------------------------------------------------------------------------
                                    (Street)

  St. Louis                MO                   63144
- --------------------------------------------------------------------------------
   (City)               (State)                 (Zip)

================================================================================
2. Issuer Name and Ticker or Trading Symbol

   KV Pharmaceutical Company; KVA & KVB

================================================================================
3. IRS or Social Security Number of Reporting Person (Voluntary)

================================================================================
4. Statement for Month/Year

   May, 1997
================================================================================
5. If Amendment, Date of Original (Month/Year)

================================================================================
6. Relationship of Reporting Person to Issuer
   (Check all applicable)

   [ X ]   Director                             [ X ]   10% Owner
   [ X ]   Officer (give title below)           [   ]   Other (specify below)

                    Vice Chairman and Chief Executive Officer
================================================================================
7.  Individual or Joint/Group Reporting
    [ X ] Form Filed by One Reporting Person
    [   ] Form Filed by More Than One Reporting Person

<PAGE>
================================================================================
           Table I -- Non-Derivative Securities Acquired, Disposed of,
                             or Beneficially Owned
================================================================================
<TABLE>
<CAPTION>
                                                                                                                6.
                                                                 4.                              5.             Owner-
                                                                 Securities Acquired (A) or      Amount of      ship
                                                    3.           Disposed of (D)                 Securities     Form:     7.
                                                    Transaction  (Instr. 3, 4 and 5)             Beneficially   Direct    Nature of
                                      2.            Code         ------------------------------- Owned at End   (D) or    Indirect
1.                                    Transaction   (Instr. 8)                (A)                of Month       Indirect  Beneficial
Title of Security                     Date          ------------     Amount   or     Price       (Instr. 3      (I)       Ownership
(Instr. 3)                            (mm/dd/yy)     Code     V               (D)                and 4)         (Instr.4) (Instr. 4)
- ------------------------------------------------------------------------------------------------------------------------------------
<S>                                   <C>            <C>      <C>    <C>      <C>    <C>         <C>            <C>       <C>

Class A Common Stock                  5/15/97        G        V      700      D                  62,558         D
- ------------------------------------------------------------------------------------------------------------------------------------
Class B Common Stock                                                                             97,450         D
- ------------------------------------------------------------------------------------------------------------------------------------
Class A Common Stock                                                                          1,878,312         I         (a)
- ------------------------------------------------------------------------------------------------------------------------------------
Class B Common Stock                                                                          1,918,312         I         (a)
- ------------------------------------------------------------------------------------------------------------------------------------
Class A Common Stock                                                                            117,500         I         (b)
- ------------------------------------------------------------------------------------------------------------------------------------
Class B Common Stock                                                                            117,500         I         (b)
- ------------------------------------------------------------------------------------------------------------------------------------
Class A Common Stock                                                                              2,009         I         (c)
- ------------------------------------------------------------------------------------------------------------------------------------
Class B Common Stock                                                                              6,602         I         (c)
- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

====================================================================================================================================
</TABLE>

<PAGE>
FORM 4 (continued)

Table    II --  Derivative  Securities  Acquired,  Disposed of, or  Beneficially
         Owned (e.g., puts, calls, warrants, options, convertible securities)

================================================================================
<TABLE>
<CAPTION>
                                                                                                          9.        10.
                                                                                                          Number    Owner-
                                                                                                          of        ship
                    2.                                                                                    Deriv-    of
                    Conver-                    5.                              7.                         ative     Deriv-   11.
                    sion                       Number of                       Title and Amount           Secur-    ative    Nature
                    of                         Derivative    6.                of Underlying     8.       ities     Secur-   of
                    Exer-             4.       Securities    Date              Securities        Price    Bene-     ity:     In-
                    cise     3.       Trans-   Acquired (A)  Exercisable and   (Instr. 3 and 4)  of       ficially  Direct   direct
                    Price    Trans-   action   or Disposed   Expiration Date   ----------------  Deriv-   Owned     (D) or   Bene-
1.                  of       action   Code     of(D)         (Month/Day/Year)            Amount  ative    at End    In-      ficial
Title of            Deriv-   Date     (Instr.  (Instr. 3,    ----------------            or      Secur-   of        direct   Owner-
Derivative          ative    (Month/  8)       4 and 5)      Date     Expira-            Number  ity      Month     (I)      ship
Security            Secur-   Day/     ------   ------------  Exer-    tion               of      (Instr.  (Instr.   (Instr.  (Instr.
(Instr. 3)          ity      Year)    Code V    (A)   (D)    cisable  Date     Title     Shares  5)       4)        4)       4)
- ------------------------------------------------------------------------------------------------------------------------------------
<S>                 <C>      <C>      <C>  <C>  <C>   <C>    <C>      <C>      <C>       <C>     <C>      <C>       <C>      <C>

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

====================================================================================================================================
</TABLE>
Explanation of Responses:
(a)   Shares held in four trusts in which the  reporting  person is one of three
      trustees of each trust; including, Trust Agreement dated 12/22/73 FBO Marc
      S. Hermelin, in which the reporting person is the primary beneficiary, and
      three other trusts  including  Trust Agreement dated 12/12/73 FBO Minnette
      Hermelin,  Trust  Agreement dated 12/22/73 FBO Anne S. Kirschner and Trust
      Agreement 12/22/73 FBO Arnold L. Hermelin.

(b)   Shares  held in an  irrevocable  trust for the  benefit  of the  reporting
      person.  The reporting person does not hold or share voting or dispositive
      power regarding the shares.

(c)   Shares held in the reporting person's 401(k) and profit sharing plans. The
      reporting person does not have voting power regarding these shares.



        /s/ Marc S. Hermelin                                     6/9/97
- ---------------------------------------------            -----------------------
        Signature of Reporting Person                             Date


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission